University of California Irvine-Led Team Develops Transplant Biomaterial That Doesn't Trigger Immune Response
June 03, 2021
June 03, 2021
IRVINE, California, June 3 (TNSJou) -- The University of California Irvine campus issued the following news release:
A multidisciplinary research team led by Jonathan Lakey, Ph.D., professor of surgery and biomedical engineering at the University of California, Irvine, has developed a biomaterial for pancreatic islet transplants that doesn't trigger the body's immune response. Based on stem cell technology, hybrid alginate offers a possible long-term treatment for Type 1 d . . .
A multidisciplinary research team led by Jonathan Lakey, Ph.D., professor of surgery and biomedical engineering at the University of California, Irvine, has developed a biomaterial for pancreatic islet transplants that doesn't trigger the body's immune response. Based on stem cell technology, hybrid alginate offers a possible long-term treatment for Type 1 d . . .